#PPI and lupus erythematosus. #dermatology #dermtwitter

In this case series using 2 large pharmacovigilance databases, proton pump inhibitors were associated with pharmacovigilance signals for the occurrence of drug-induced lupus erythematosus. https://t.co/4hcmacexVh

— JAMA Dermatology (@JAMADerm) November 12, 2022